Treatment of surgically resectable non-small-cell lung cancer in elderly patients.
Lung cancer is the leading cause of cancer mortality in the United States. The median age of diagnosis is 69 years and the number of elderly patients with lung cancer is expected to increase as this segment of the population increases. This review article describes surgical resection, rationale for adjuvant therapy, and the role of molecular markers in this growing patient population.
Haithcock
Benjamin E
BE
Multidisciplinary Thoracic Oncology Program, Division of Cardiothoracic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7065, USA. bhaithco@med.unc.edu
Stinchcombe
Thomas E
TE
Socinski
Mark A
MA
D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant / Q000379:methods*; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D020775:Thoracic Surgery, Video-Assisted / Q000379:methods; D014481:United States / Q000453:epidemiology
D014408:Biomarkers, Tumor